Eyes on New Product Development

Abstract

Get full access to this article

View all access options for this article.

References

Novack

G.D.

, and Barnett

Ocular drug delivery systems using contact lenses. J. Ocul. Pharmacol. Ther. 36:595–601, 2020.

Yang

What do we know about remdesivir drug interactions?. Clin. Transl. Sci. 13:842–844, 2020.

Brunsdon

, Saluja

, and Sahajwalla

Clinical pharmacology considerations for developing small-molecule treatments for COVID-19. J. Clin. Pharmacol. 60:1147–1154, 2020.

Novack

G.D.

Repurposing medications. Ocul. Surf. 19:336–340, 2021.

Nguyen

, Hampton

, and Eydelman

M.B.

FDA facilitating innovation of ophthalmic devices while balancing the need for safety and effectiveness. JAMA Ophthalmol. 2022 [Epub ahead of print]; DOI: 10.1001/jamaophthalmol.2022.0167.

Novack

GD.

Product exclusivity granted by the U.S. Food and Drug Administration. Ocul. Surf. , 14:74–76, 2016.